KLK3 and prostate cancer: There are many clinically relevant biomarkers identified for pathologies, such as troponins for acute myocardial infarction [105], prostate-specific antigen (PSA) for prostate cancer [106], or C-reactive protein (CRP) for inflammation or infection processes [13,107].